Cetera Investment Advisers’s CalciMedica CALC Stock Holding History

Cetera Investment Advisers’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,290	Closed	-$147K	–	4827
2025 Q4	$147K	Sell	22,290 -3,075	-12%	-$12K	﹤0.01%	4310
2025 Q3	$78K	Sell	25,365 -11,020	-30%	-$31.7K	﹤0.01%	4370
2025 Q2	$58.2K	Buy	36,385 +9,045	+33%	+$15.5K	﹤0.01%	3960
2025 Q1	$52.2K	Buy	27,340 +10,467	+62%	+$26.1K	﹤0.01%	3854
2024 Q4	$59.7K	Buy	16,873 +4,566	+37%	+$16K	﹤0.01%	3643
2024 Q3	$54.5K	Buy	+12,307	New	+$54.1K	﹤0.01%	3595

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cetera Investment Advisers's CALC Position: Q1 2026 in Review

Cetera Investment Advisers sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 22,290 shares — an estimated $147K sold.

Cetera Investment Advisers first reported a position in CALC in Q3 2024 and held it in 6 quarters. The position peaked at $147K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

Cetera Investment Advisers reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
Cetera Investment Advisers sold 22,290 CalciMedica shares in Q1 2026, an estimated $147K.
Cetera Investment Advisers first reported a position in CalciMedica in Q3 2024 and held it in 6 quarters.
Cetera Investment Advisers's CalciMedica position peaked at $147K in Q4 2025.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.